NLC ventures NC Biomatrix and MLA Diagnostics receive grants for further developing business model, market strategy and R&D trajectory.

Both NC Biomatrix and MLA Diagnostics have received an MIT grant. The money will be used to further develop their business model, market strategy and R&D trajectory.

Given the tight competition, this shows that both NC Biomatrix and MLA Diagnostics are working on truly innovative projects that have the ability to change patients’ lives across the globe.